![]() (Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the nine-month period ended 30 September 2022, reporting revenue (compliant with IFRS) of EGP 2.8 billion. Integrated Diagnostics Holdings Plc reports sustained growth in non-Covid offering showcasing the fundamental strength and potential of the business Thorpematt, do you still hold?īusiness on the ground appears to be doing well, though depreciation of the EGP. Posted at 11:10 by brucie5 hTTps://uk. /stock-market/london /integrated-diagnost ics-IDHC/share-news/ Integrated-Diagnosti cs-Holdings-PLC-3rd- Quarter-Re/89576886 Note: Though yielding above average for his folio, IDHC did not satisfy this last bit about director buy-backs, though as stated in previous posts, the CEO has a very high level of share ownership already! This is a very reasonable income from a (hopefully) well-protected portfolio. This portfolio is forecast to yield 7.2%, and 17 of the constituents have bought back shares within the last month. TTM Dividend Yield, Rank in Industry Group > 60%ġ-Year Rolling Dividend Yield, Rank in Industry Group > 60% He used this screen to generate the folio: HTTps://app.stockope dia.com/content/buil ding-a-safer-income- portfolio-without-sa crificing-the-yield- 956194?order=created At&sort=desc& mode=threaded Important to stress it's a highly diversified folio, so can afford some geographically specific headwinds - no doubt the case with IDHC. Posted at 14:41 by brucie5 Finally - (and then I'll stop!) I notice that IDHC was included in Mark Simpson's 40 stock folio for income investing, back on October 26.
0 Comments
Leave a Reply. |